Overview of annual transition probabilities and cost variables used in the Markov model.

HCV: hepatitis C virus.HCC: hepatocellular carcinoma.#In the prevalence a clearance rate of 42% [14] was included. The prevalence used in the model for all pregnant women is 0.2% (9/4563; 95% CI: 0.10–0.37) and for first generation non-Western women 0.43% (7/1612; 95% CI 0.21–0.89).$Transition rate is age-dependent.*same distribution was used for first-generation non-Western women.**new protease inhibitors are added to the standard of care regimen (peginterferon alfa and ribavirine).